Epicrispr Biotechnologies

Developer of gene therapies designed to treat various genetic diseases that currently lack effective treatments. The company focuses on precisely regulating gene activity by turning genes on or off th...

Healthcare
San Francisco, CA, United States
Founded 2018
40 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$123M
Last Round
N/A

Get the full picture

Create a free account to unlock Epicrispr Biotechnologies's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required